ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2785

Urinary Inflammatory Cells Strongly Reflect the Disease Activity and Renal Function in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Yoko Wada1, Minoru Sakatsume2, Masaaki Nakano3 and Ichiei Narita1, 1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 3School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ANCA

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The antineutrophil cytoplasmic autoantibody (ANCA)- associated vasculitides (AAVs) include microscopic polyangiitis (MPA), granulomatosis with polyangitis (GPA; formerly Wegener’s), and eosinophilic granulomatosis with polyangitis (EGPA). These small-vessel vasculitides are characterized by necrotizing inflammation of the vessel wall, particularly affecting small arteries, arterioles, and capillaries in systemic organs, and the kidney is one of the most frequently involved organs. We have already reported that T cells and macrophages appear in the urine of patients with glomerulonephritis, accompanied by active cellular infiltration such as cellular crescent formation and diffuse interstitial cell infiltration, but not in the urine of patients with glomerulonephritis without the active inflammatory lesions. In this study, we examined the correlation between the numbers of urinary inflammatory cells and disease activity in AAVs, and assessed the utility of urinary immune cell analysis.

Methods:

Thirty patients with AAVs (MPA; n=26, GPA; n=3, EGPA; n=1), who had been referred to Niigata University Hospital between 2004 and 2012, were recruited for this study. The patients were divided into two groups according to clinical renal function (renal involvement (RI) group, n=24); non-renal involvement (non-RI) group, n=6)). Flow-cytometric analysis of urinary inflammatory cells was performed for each subject. Numbers of urinary T cells or macrophages were determined by multiplying the number of viable cells in the gated mononuclear cell region in each sample by the percentage of urinary CD3-positive or CD14-positive cells in the population, respectively. The numbers of urinary CD3-positive cells and CD14-positive cells, laboratory data including the titers of serum ANCA, serum creatinine and C-reactive protein, and the Birmingham vasculitis activity score (BVAS), were examined in each subject, and compared between the RI and non-RI groups. We then examined the correlations between the numbers of CD3-positive or CD-14-positive cells and laboratory data and BVAS by Spearman’s rank correlation coefficient in all subjects.

Results:

The total numbers of urinary CD3-positive cells and CD14-positive cells were significantly elevated (>120/ml urine) in all patients in the RI group and 5 of 6 patients in the non-RI group. The number of urinary CD3-positive cells was positively correlated with the titer of serum ANCA (r=0.41, p=0.02) and BVAS (r=0.38, p=0.038), while the number of urinary CD14-positive cells was positively correlated with serum Cr (r=0.38, p=0.038) and negatively correlated with eGFR (r=-0.38, p=0.03).

Conclusion:

These results indicate the usefulness of urinary immune cell analysis for assessment of both kidney function and disease activity in patients with AAVs.


Disclosure:

Y. Wada,
None;

M. Sakatsume,
None;

M. Nakano,
None;

I. Narita,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/urinary-inflammatory-cells-strongly-reflect-the-disease-activity-and-renal-function-in-antineutrophil-cytoplasmic-autoantibody-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology